HuGE Literature Finder
Records 1-19
|
NT-proBNP level in stage 3-4 chronic kidney disease and mortality in long-term follow-up: HAPPY study subgroup analysis.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 2020 Jul 48 (5): 454-460. Simsek Mustafa Aytek, Degertekin Muzaffer, Türer Cabbar Ayça, Hünük Burak, Aktürk Serkan, Erdogmus Siyar, Mutlu Bülent, Kozan Öm |
|
Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment.
Journal of clinical medicine 2020 Jun 9 (6): . Nakao Akira, Hiranuma Osamu, Uchino Junji, Sakaguchi Chikara, Araya Tomoyuki, Hiraoka Noriya, Ishizuka Tamotsu, Takeda Takayuki, Kawasaki Masayuki, Goto Yasuhiro, Imai Hisao, Hattori Noboru, Nakatomi Keita, Uramoto Hidetaka, Uryu Kiyoaki, Fukuda Minoru, Uchida Yasuki, Yokoyama Toshihide, Akai Masaya, Mio Tadashi, Nagashima Seiji, Chihara Yusuke, Tamiya Nobuyo, Kaneko Yoshiko, Mouri Takako, Yamada Tadaaki, Yoshimura Kenichi, Fujita Masaki, Takayama Koic |
|
Clinical significance of anemia as a prognostic factor in non-small cell lung cancer carcinoma with activating epidermal growth factor receptor mutations.
Journal of thoracic disease 2020 May 12 (5): 1895-1902. Kang Hye Seon, Shin Ah Young, Yeo Chang Dong, Park Chan Kwon, Kim Ju Sang, Kim Jin Woo, Kim Seung Joon, Lee Sang Haak, Kim Sung Kyou |
|
Osimertinib, a third-generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real-world efficacy and safety in advanced/recurrent non-small cell lung carcinoma.
Thoracic cancer 2020 Mar . Kishikawa Takayuki, Kasai Takashi, Okada Masahiko, Nakachi Ichiro, Soda Sayo, Arai Ryo, Takigami Ayako, Sata Masafu |
|
Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III Study.
Clinical colorectal cancer 2020 Mar . Chibaudel Benoist, André Thierry, Tournigand Christophe, Louvet Christophe, Benetkiewicz Magdalena, Larsen Annette K, de Gramont Aime |
|
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study.
BMC cancer 2018 Dec 18 (1): 1231. Tsutani Yasuhiro, Miyata Yoshihiro, Masuda Takeshi, Fujitaka Kazunori, Doi Mihoko, Awaya Yoshikazu, Kuyama Shoichi, Kitaguchi Soichi, Ueda Kazuhiro, Hattori Noboru, Okada Morihi |
|
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations.
Cancer chemotherapy and pharmacology 2018 May . Imai Hisao, Minemura Hiroyuki, Sugiyama Tomohide, Yamada Yutaka, Kaira Kyoichi, Kanazawa Kenya, Kasai Takashi, Kaburagi Takayuki, Minato Koichi, |
|
Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
Clinical lung cancer 2018 11 19 (6): 484-492. Xie Hounai, Wang Hui, Xu Lin, Li Meng, Peng Yue, Cai Xianyun, Feng Zhen, Ren Wangang, Peng Zhongm |
|
A polymorphism at IGF1 locus is associated with anemia.
Oncotarget 2017 Mar . Marini Maria Adelaide, Mannino Gaia Chiara, Fiorentino Teresa Vanessa, Andreozzi Francesco, Perticone Francesco, Sesti Giorg |
|
Sickle Cell Trait and Renal Function in Hispanics in the United States: The Northern Manhattan Study.
Ethnicity & disease 2017 Jan 27 (1): 11-14. Dueker Nicole D, Della-Morte David, Rundek Tatjana, Sacco Ralph L, Blanton Susan |
|
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations.
The Korean journal of internal medicine 2016 Nov 31 (6): 1140-1149. Park Sehhoon, Park Seongyeol, Lee Se-Hoon, Suh Beomseok, Keam Bhumsuk, Kim Tae Min, Kim Dong-Wan, Kim Young Whan, Heo Dae Se |
|
Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis.
Meta gene 2016 Sep 9 110-9. Zhou Mingyi, Yu Ping, Hou Kezuo, Fu Lingyu, Chen Ying, Qu Jinglei, Qu Xiujuan, Liu Yunpeng, Zhang Jingdo |
|
Efficacy of epidermal growth factor receptor inhibitors in combination with chemotherapy in advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.
Oncotarget 2016 May . Zhang Minghui, Guo Hongsheng, Zhao Shu, Wang Yan, Yang Maopeng, Yu Jiawei, Yan Yubo, Wang Y |
|
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
AIDS (London, England) 2016 May . Kheloufi Farid, Bellissant Eric, Cotte Laurent, Poizot-Martin Isabelle, Quaranta Sylvie, Garraffo Rodolphe, Barrail-Tran Aurélie, Renault Alain, Fournier Isabelle, Lacarelle Bruno, Bourlière Marc, Molina Jean-Michel, Solas Caroline, |
|
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar . Pietanza Catherine M, Hellmann Matthew D, Fiore John J, Smith-Marrone Stephanie, Basch Ethan M, Schwartz Lawrence H, Ginsberg Michelle S, Shouery Marwan, Newman Samantha K, Shaw Mary, Rogak Lauren J, Lash Alex, Hilden Patrick, Kris Mark |
|
Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy.
Antimicrobial agents and chemotherapy 2015 Jun 59 (6): 3257-62. Gutierrez-Valencia Alicia, Ruiz-Valderas Rosa, Ben-Marzouk-Hidalgo Omar J, Torres-Cornejo Almudena, Espinosa Nuria, Castillo-Ferrando Juan R, Viciana Pompeyo, Lopez-Cortes Luis |
|
The efficacy and safety of EGFR inhibitor monotherapy in non-small cell lung cancer: a systematic review.
Current oncology reports 2014 Jun 16 (6): 390. Yang XiongWen, Yang Ke, Kuang Kang |
|
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
Investigational new drugs 2012 Jun 30 (3): 1164-74. Oh Do-Youn, Lee Keun Wook, Lee Kyung-Hee, Sohn Chang-Hak, Park Young Suk, Zang Dae Young, Ryoo Hun-Mo, Song Hong-Suk, Kim Jin-Soo, Kang Hye-Jin, Kim Bong-Seog, Bang Yung-J |
|
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
The New England journal of medicine 2010 Jun 362 (25): 2380-8. Maemondo Makoto, Inoue Akira, Kobayashi Kunihiko, Sugawara Shunichi, Oizumi Satoshi, Isobe Hiroshi, Gemma Akihiko, Harada Masao, Yoshizawa Hirohisa, Kinoshita Ichiro, Fujita Yuka, Okinaga Shoji, Hirano Haruto, Yoshimori Kozo, Harada Toshiyuki, Ogura Takashi, Ando Masahiro, Miyazawa Hitoshi, Tanaka Tomoaki, Saijo Yasuo, Hagiwara Koichi, Morita Satoshi, Nukiwa Toshihiro, |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jun 23, 2021
- Content source: